Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
wow... really taking off with this big news..lol.. 4 or 5 Biotech stocks go up hundreds % a day on way lesser/but probably REAL news. Not this stock selling scam from India.. sad
Wow.. big news this morning.. lol is it? All it is is more dilution heading towards the reverse split. They got a few new suckers to buy in the 1.20's pre market... Why does no one buy any? Everyone knows this is a stock selling scam from India.
Uh Oh.... looks like they did not like what they saw on Saturday's vague bs presentation. Little volume of some fomo on Friday afternoon.. they found another sucker investor. Reality sets back in today... they have nothing... they are nothing.. back under a dollar... most likely for good... until the reverse split to wipe out all current investors.
That's awesome! You keep paying interest on your short of NVDA. Pretty soon you'll have paid more in interest than the stock price. Then betting on your penny stocks. I think you invest backwards, but who cares?
I think you give yourself way too much credit that anyone cares whether or not you stay on IHUB. Based on what I've read of your posts, you're pretty vanilla.
And once again you try to put words in my mouth. I have no opinion on this stock and don't care. I said buying all penny stocks is stupid.
my short on NVDA isn't a day trade - i will hold for another year or so - as long as it takes. I'll cover at maybe $20 or $25 - even though i think it will eventually bottom at $15 or lower. But i don't want to argue about it - life is too short. you don't have to join, but i stick to my word. In fact, if it's higher than even $100 by year end, i'll delete all of my accounts from every board. I'm sure some people will be thrilled with that :)
RNXT is a call option. It could succeed, or it could fail. But.....their current, well-enrolled trial is playing out as we speak - and nothing we say or do on an anonymous chatboard here can change the results by even 1% - isn't that great?
So, let's see where we are at year end / early next year. you say it will fail - well, there's another bet i'll take anytime.
Starting to have sells after hours.. this one is under a dollar for good I believe.. they will reverse split and then run another one day scam like a lot of the bio's are doing every day now. IT'S TOAST
Considering I'm diversified I'm just dandy. My accounts have been up as late.
Of course, if you took the time to actual look at my posts, I've been advising people to wait to buy SMCI in the low $300's, so not really sure who you think you're schooling? Go back and look at my board as I post most buys and sells. I made over 1200% on SMCI by buying it at $37.
You see, if you were a big time investor, you wouldn't need to day trade.
P.S NVDA is very close to its support level and probably an add here....but you keep shorting.
how's that long NVDA and SMCI position taste? i am printing money on the short side. may close SMCI for 70% over just a few months. But on NVDA, there is a loooooong way to go :)
not your fault though - you're just another typical retail clown. betting against someone like you is the proverbial taking candy from a baby.
So, basically, you're a moron.
I don't care if I leave here or not. I've left for 3 years at a time.
If you choose not to learn how to invest, that's on you.
In fact, you should load up on this penny stock. Take out a second mortgage.
hey look - if you're too chicken to take the bet, that's fine. you can write 3 paragraphs, but either put up or shut up.
OK, so with a little time to kill, I just read most of your posts on the CYDY board.
The good news is, I don't believe you to be one of the scammers (like monroe and a couple others)...
however, I'm not quite convinced that 7 years is enough education for you...for instance...tell me the post below was before you came to your senses and and at the very least, sold off your cost basis??
First off, I couldn't care less if you delete your account or not. Delete, don't, post under 10 aliases....makes no matter to me.
Secondly....
well, it comes down to sizing. these pre-revenue biotechs are small relative to my other holdings, so i've sized them correctly. But in terms of missing the point - just so that i'm clear, you're saying that RNXT will tank before their 60% readout in 4 months?
Tell you what. Let's check back in 3 months - beginning of November. Let's see:
1. What the price of NVDA is relative to 128.6, where i went short.
2. If RNXT is still in business.
If either NVDA is higher, or RNXT has tanked, I will delete all of my accounts and never post again. But, if NVDA is down and RNXT is still kicking, you have to do the same. Up for the wager?
You're missing the point. Any company using Aegis as a lender will tank. Their toxic finance deals leave no way out.
SMCI may pull back further in the short term, however, they have a future P/E of 17 currently.
Considering how quickly it can rise, not sure I'd want to trying to guess how far it will fall.
You're buying penny stocks and shorting stocks with strong earnings....not sure I'd consider this investing. Better off playing red/black on the roulette wheel in Vegas and get free drinks.
well, the good news is we'll know one way or the other by year end, when trial results come out. not much need to discuss before then - it'll either be good or bad, and nothing else said will affect that. I have never claimed to know for sure. But, here we have a tangible milestone within months - it's coming. CytoDyn doesn't have such a milestone, which is why i'm concerned about that one.
I just re-loaded my short on NVDA and SMCI. I guess we'll find out who's right :)
I thought I'd check out your other investments. I only get 1 post per day on CYDY.
However, often times I am surprised that a poster makes a perfectly rational post on one penny stock board, but then is sucked in by another.
I spent about 3 minutes investigating this stock before noticing they are attached to Aegis Capital, who is a known toxic spiral finance company.
Any company using them WILL tank, and I notice this one is falling. If they are in any way legit, they will have to do a reverse split to get the share price back above $5, them's just the facts.
You state you've never shorted a stock. Me neither. Although I've seen so many stocks I should be. ALL stocks tend to drop twice as quickly as they rise, but I would rather stay conservative.
Why not invest in real companies with real earnings? I made 16% in SMCI just last week! There is so much money to be made right now in the stock market and you're attaching yourself to this anchor?
Kinda sad when you think about it... more vague news today and no one cares or trusts this company. Look at the names running it.
They even bought some shares right before the close yesterday (12k only lol...) then 2500 pre market to make this big news release of vague information that they have repeated in pr's about 5 times now. This company has nothing i'm afraid.
At least 2 bio stocks are popping 200-500% a day for two weeks now... and this pos with dumb board members slowly continues it's death march. Pitiful.
University of Nebraska Medical Center Launches Patient Enrollment for RenovoRx’s Pivotal Phase III TIGeR-PaC Clinical Trial
https://finance.yahoo.com/news/university-nebraska-medical-center-launches-123000558.html
RNXT.......................................................................https://stockcharts.com/h-sc/ui?s=RNXT&p=W&b=5&g=0&id=p86431144783
uh oh... being covered by a never heard of pos analyst Ascendiant Capital... 8.00 target usually means we are going to .80
Hope not. We don't need this bs pump crap. Just stay above a dollar until phase III results are in. Looks bad.
More and more selling. Wonder what is going on and who is getting out?
This clearly now seems to be in sell off mode. Or someone big is getting out. Looks like we are heading back under a dollar. Sad.
THE SELL DAYS ARE GETTING A LITTLE BIGGER... I HOPE IT IS NOT SOMEONE IN THE KNOW...
Looks like the update to the Shareholders might have been the kiss of death. Hope not. This thinly of a traded stock can plummet in no time. Can skyrocket too... I just don't see a catalyst for that to happen. I'm hoping phase III is not already baked in the price... then we would have no hope.
RenovoRx CEO Issues Update Letter to Shareholders (NASDAQ: RNXT)
https://www.businesswire.com/news/home/20240529881953/en/RenovoRx-CEO-Issues-Update-Letter-to-Shareholders
I can't believe with this news this morning nothing happens.. dropped the bid down to 1.10 ... must have a big sell block or something?
This should be flying on this news.
Weird trading going on...I guess it is better than selling... seems like it's being propped up for some reason... wonder what it can be?
Tough Q2 for most med tech stocks
Allow me to demonstrate
Observe the graph at the top of the webpage
https://www.barchart.com/stocks/quotes/RNXT/competitors?quoteSectors=-MEBI&viewName=main&orderBy=weightedAlpha&orderDir=desc
I get that.. you said Under 2.00? It is already way under 2.00?
Valuations for about all stocks in the med tech sector of 459 issues have been declining since February and shows little evidence of bottoming
Yes it is under $2.00. Are you saying it is a bargain under $2.00?
Please advise.. thank you
Very very quiet.... no trades really to speak of ... very low volume. Will there be a catalyst to move the sp this year?
Anyone know?
Good morning RNXT'ers.. anyone know if the new private placement has closed? Sometimes stocks get a bump when done. Especially if there are big investors waiting to make sure the company is funded enough to get to the end. Good luck.
I wonder if it closed yesterday? Sometimes when they do it gives the sp a bump. This one is so thinly traded it may not. Or it could be bigger...
"The definite subscription agreements were executed based on the closing price of RenovoRx’s common stock on April 4, 2024, and the private placement is expected to close on April 11, 2024, subject to customary closing conditions. Newbridge Securities Corporation is acting as sole placement agent for the transaction."
Good morning... i'am done being negative on this board about this stock. I was never short the stock. Just a furious stock holder that knew he was locked into a sinking ship stock. I'm sure all the stupid angry things I said about the stock did not influence it in any way. I have watched many of these small companies... some personally owning and some to watch a comparison... I have never seen one make it that get to this point. Lost a bundle on this one. The story is clever... hope it does spike for everyone. I personally don't see how or why.. share count is rising ect... guess we will see. Good luck if you hold it.
OK.. first off... how did the offering go very quickly? What do you mean? Why are they reputable? You really sound like you work for the company.
why regret not buying more? It's only 1.18 right now. What are you hoping for?
after this placement they are getting up there in shares now. These companies love reverse splits to wipe out current holders and make it more attractive for future (I call them suckers..) you call them what you want.
Who are these to reputable firms that say RNXT is worth 4.00 now and way higher with approval?
is this Raj?
please advise
fantastic news. sounds like the offering went very quickly and easily - always a great sign, and run by a reputable bank. this gives the company enough financial runway to reach 2026 - the financial uncertainty is now completely off the table. my only regret was not adding more up to this point - but now that there is more volume / liquidity in the market, i will add steadily on any pullbacks.
for those who are curious, there are 2 research report out by reputable firms on RNXT that delve deep into the technology and the underlying company. Both have price targets of $4 on the stock. Of course, the potential is a large multiple of that number - as the $4 is fair value today (discounting an eventual approval which will cause the price to skyrocket).
LOL... no one sell.. this gives them cash til 2026. Everyone hold their shares til at least then... WHILE THEY DUMP THEIERS!!! LOL.. MORE BS.
OMG.. don't people read before reacting? New dummies paid 1.80 on this bogus news. Already down .60 on those..lol. Nothing has changed except more shares issued for the upcoming reverse stock split.
SLOW STEADY SELL OFF CONTINUES.. THINLY TRADED STOCKS WITHOUT CONTINUOUS SUCKERS TAKE TIME TO DUMP WITHOUT DRIVING IT TO ZERO... RAJ MUST NEED SOME MONEY THIS WEEKEND. STOCK SELLING SCAM FROM INDIA.
RNXT annual report came out this morning... too many shady things to bring up.. I will just bring up the new registered share count...just under 17 million.. already? Just giving away shares to themselves and anyone else they can scam.. Not good.. Reverse split coming sooner than later. All current shareholders will be wiped out.
1.25 ......lol.. Raj is getting you again.. going under a dollar... will reverse split and wipe out all the dumb investors that have hung on.. (they are not in business to help you) .. then start over with out in the future predictions... lol.. stock selling scam from India
Boy oh boy.. investors must have really liked what they heard... 147 shares traded already today... only 11:30.... watch out for the power hour... poor Raj... got to be a paper churning stock selling scam from India the hard way.
Presentation must have went great today... Investors poured in.. no new suckers for Raj and his stock selling scam from India.
sell off soon will drive this way below a buck followed by a reverse split.
Followers
|
8
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
224
|
Created
|
08/31/21
|
Type
|
Free
|
Moderators |
RenovoRx is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. We are committed to developing transformative therapies for improved quality of life and extended life in cancer patients.
Developing Innovative Combination Therapies for Targeted Treatment of Difficult-to-Access Cancers
The Phase III TIGeR-PaC clinical trial is an ongoing randomized multi-center study using RenovoRx’s innovative therapy platform, Trans-Arterial Micro-Perfusion (TAMP™), to evaluate RenovoRx’s first product candidate, RenovoGem™. The study is evaluating trans-arterial delivery, a form of intra-arterial administration, of an FDA-approved chemotherapy, gemcitabine, to treat LAPC following stereotactic body radiation therapy (SBRT). The study is comparing treatment of gemcitabine with TAMP versus systemic IV administration of gemcitabine and nab-paclitaxel.
RenovoRx’s proprietary Trans-Arterial Micro-Perfusion (TAMP) therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy’s toxicities versus systemic (intravenous (IV) therapy). RenovoRx’s unique approach to targeted treatment offers the potential for increased safety, tolerance, and improved efficacy. Our Phase III lead product candidate, RenovoGem, a novel oncology drug-device combination product, is being investigated under a US IND that is regulated by FDA 21 CFR 312 pathway. RenovoGem is currently being evaluated for the treatment of locally advanced pancreatic cancer (LAPC) by the Center for Drug Evaluation and Research (the drug division of FDA.)
RenovoGem will also be evaluated as a potential therapy in bile duct cancer, with a Phase III clinical trial expected to begin in late 2023 with other potential pipeline indication opportunities to follow including non-small cell lung cancer, uterine tumors, glioblastoma, and sarcoma. RenovoGem received FDA Orphan Drug Designation for pancreatic cancer and bile duct cancer which provides 7 years of market exclusivity upon NDA approval.
Nothing in the contents transmitted on this board should be construed as an investment advisory, nor should it be used to make investment decisions.
There is no express or implied solicitation to buy or sell securities.
The author(s) may have positions in the stocks or financial relationships with the company or companies discussed and may trade in the stocks mentioned.
Readers are advised to conduct their own due diligence prior to considering buying or selling any stock. All information should be considered for information purposes only.
No stock exchange has approved or disapproved of the information here.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |